Medically Refractory Lymphocytic Colitis Successfully Treated With Upadacitinib

被引:5
作者
Miyatani, Yusuke [1 ]
Choi, David [1 ]
Du, Xiaotang [2 ]
Hart, John [2 ]
Rubin, David T. [1 ]
机构
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Dept Med, Chicago, IL 60637 USA
[2] Univ Chicago Med, Dept Pathol, Chicago, IL USA
关键词
lymphocytic colitis; microscopic colitis; upadacitinib; MICROSCOPIC COLITIS; THERAPY;
D O I
10.14309/crj.0000000000000979
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Lymphocytic colitis is a microscopic colitis characterized endoscopically by nearly normal-appearing colonic mucosa and histology demonstrating intraepithelial lymphocytosis. Microscopic colitis that is refractory to conventional therapies, including budesonide, is rare but challenging and with scarce evidence. Upadacitinib is a novel Janus kinase 1 selective inhibitor approved by the US Food and Drug Administration for atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and moderately to severely active ulcerative colitis. We present the first case of lymphocytic colitis refractory to conventional and immunosuppressive therapies, which responded promptly to upadacitinib.
引用
收藏
页数:4
相关论文
共 18 条
[1]   Vedolizumab for the Treatment of Noninflammatory Bowel Disease Related Enteropathy [J].
Akhtar, Hisham J. ;
Nguyen, Tran M. ;
Ma, Christopher ;
Jairath, Vipul .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) :E614-E623
[2]   Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? [J].
Baker, Kenneth F. ;
Isaacs, John D. .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) :175-187
[3]   Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID [J].
Boivineau, Gregoire ;
Zallot, Camille ;
Zerbib, Franck ;
Plastaras, Laurianne ;
Amiot, Aurelien ;
Boivineau, Lucile ;
Koch, Stephane ;
Peyrin-Biroulet, Laurent ;
Vuitton, Lucine .
JOURNAL OF CROHNS & COLITIS, 2022, 16 (12) :1816-1824
[4]   Microscopic colitis [J].
Burke, Kristin E. ;
D'Amato, Mauro ;
Ng, Siew C. ;
Pardi, Darrell S. ;
Ludvigsson, Jonas F. ;
Khalili, Hamed .
NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
[5]   Immune modulator therapy for microscopic colitis in a case series of 73 patients [J].
Cotter, T. G. ;
Kamboj, A. K. ;
Hicks, S. B. ;
Tremaine, W. J. ;
Loftus, E. V. ;
Pardi, D. S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (02) :169-174
[6]   Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients [J].
Daferera, Niki ;
Hjortswang, Henrik ;
Ignatova, Simone ;
Munch, Andreas .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (09) :1234-1240
[7]  
Danese S, 2022, LANCET, V399, P2113, DOI [10.1016/s0140-6736(22)00581-5, 10.1016/S0140-6736(22)00581-5]
[8]   Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group [J].
Fernandez-Banares, F. ;
Casanova, M. J. ;
Arguedas, Y. ;
Beltran, B. ;
Busquets, D. ;
Fernandez, J. M. ;
Fernandez-Salazar, L. ;
Garcia-Planella, E. ;
Guagnozzi, D. ;
Lucendo, A. J. ;
Mancenido, N. ;
Marin-Jimenez, I. ;
Montoro, M. ;
Piqueras, M. ;
Robles, V. ;
Ruiz-Cerulla, A. ;
Gisbert, J. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (03) :400-426
[9]   Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile [J].
Kumawat, Ashok Kumar ;
Strid, Hilja ;
Tysk, Curt ;
Bohr, Johan ;
Hornquist, Elisabeth Hultgren .
MOLECULAR IMMUNOLOGY, 2013, 55 (3-4) :355-364
[10]   Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis [J].
Lasa, Juan S. ;
Olivera, Pablo A. ;
Danese, Silvio ;
Peyrin-Biroulet, Laurent .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02) :161-170